VIEWPLATE-384 TC, White, clear bottom, sterile TC treated, Case of 40 | PerkinElmer

幸运8平台彩票

PerkinElmer
check quantity

VIEWPLATE-384 TC, White, clear bottom, sterile TC treated, Case of 40

384-well tissue culture treated (TC-treated) sterile ViewPlate microplate with white well walls and a clear bottom for viewing plates under a microscope or bottom reading measurements.

部件号 6007480
立即购买

幸运8平台彩票 请输入有效的数量

幸运8平台彩票 请登录后再添加至收藏夹

购物车为空

幸运8平台彩票 项目已成功添加到购物车

详情 信息

幸运8平台彩票Our ViewPlate microplates are engineered for bottom reading systems. This high quality microplate can be utilized in your cell based assay for superior results.

幸运8平台彩票Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better microplates for better performance that guarantees better results for all PerkinElmer applications.

规格

自动化兼容 Yes
涂层处理 TC-treated, Sterile
颜色 White/Clear Bottom
检测方法 Time-Resolved Fluorescence (TRF), Luminescence, Alpha, Radiometric
Material Polystyrene
产品品牌名称 ViewPlate
运输条件 环境
Sterile Yes
产品尺寸 Case of 40
阱数量 384 well plate
资源,活动及更多信息
  • 所有

应用文献

Measuring PD-L1 Expression in Breast Cancer Cell Lines with AlphaLISA

Too many candidates, too little time. The lack of robust, rapid, high-throughput assays to identify and qualify potential therapeutic targets in areas such as cancer research continues to cost valuable time. What if you could increase assay throughput without compromising sensitivity, obtain more data points from each sample and eliminate tedious wash steps? Find out how AlphaLISA® assay technology, combined with the EnVision® multimode plate reader, provides a fast, powerful, homogeneous platform for screening potential inhibitors of PD-L1 (a protein associated with breast cancer tumor cells) expression in human cells.

PDF 4 MB
Measuring PD-L1 and PD-1 Expression in Human Cells with LANCE Ultra TR-FRET

幸运8平台彩票Immuno-oncology is an exciting area within cancer research and among the most promising approaches to activating therapeutic antitumor immunity is through the blockade of immune checkpoints. The programmed cell death-1 (PD-1) immune checkpoint pathway is a negative regulator of T cell immune function. When PD-1 is bound to programmed cell death-ligand 1 (PD-L1), T cell response is suppressed. Many tumor cells escape anti-tumor immunity through their expression of Programmed Death Ligand 1 (PD-L1 or B7-H1), which interacts with T cell-expressed PD-1 and results in T cell apoptosis. PD-L1 expression has been studied in multiple different cancers. While several anti-PD-1 or PD-L1 monoclonal antibodies that block the PD-1/ PD-L1 complex formation have been developed to date, there remains a need for more robust, rapid, high-throughput assays to identify and qualify novel inhibitors of PD-1/PD-L1 binding and assays to detect expression levels of both binding partners. Find out how LANCE® Ultra Technology provides a fast, powerful, homogeneous platform for identifying and characterizing endogenous PD-L1 and PD-1 expression in human cells.

PDF 4 MB

海报

Running an Aequorin Cell-Based Luminescent Assay on the FLIPR TETRA

幸运8平台彩票We have shown here that signal intensity for the selected catalog aequorin cell lines is strong enough to allow its measurement by the non-luminescence dedicated FLIPR

PDF 270 KB